NHS to lose out on new drugs, pharma firm Novartis warns

NHS to lose out on new drugs, pharma firm Novartis warns

Pritti MistryBusiness reporter, BBC News PA Media NHS patients will lose access to new cutting-edge treatments because of skyrocketing costs, the pharmaceutical giant Novartis has claimed amid a row over drug pricing deals. The warning comes after talks over the cost of medicines for the UK between Health Secretary Wes Streeting and pharma firms broke … Read more

US tariffs to hit textiles, gems, MSMEs hard; GDP growth forecast cut to 6%: Nomura

US tariffs to hit textiles, gems, MSMEs hard; GDP growth forecast cut to 6%: Nomura

New Delhi: India’s economy faces significant risks from steep US tariffs, with export-heavy sectors such as textiles, gems and jewellery, food and marine products likely to bear the brunt, said Aurodeep Nandi, India Economist at Nomura. While smartphones, pharma and petroleum products remain exempt, nearly 30–40% of India’s export basket is directly exposed to the … Read more

Top sectors to watch in 2025 amid global uncertainty: Expert insights for Indian investors

Top sectors to watch in 2025 amid global uncertainty: Expert insights for Indian investors

“On the other hand, emerging markets are seeing deflationary trends. The US has gained full access to manufacturing markets like Indonesia and Vietnam, which are now being flooded with cost-effective US goods. That, combined with stronger currencies, means lower prices in these markets,” says Abhishek Banerjee, CEO, LotusDew Wealth.For the first time, we are seeing … Read more

Mid and smallcap earnings to outshine Nifty 50 despite valuation concerns: Manish Sonthalia

Mid and smallcap earnings to outshine Nifty 50 despite valuation concerns: Manish Sonthalia

“All in all, largecap would have minus one to plus one sort of a CC, constant currency, growth but the better numbers would likely be from the mid-tier players in the IT space. Again, on the IT side again, I would believe that most of the negatives are broadly in the price. If we were … Read more

Chief Minister Revanth Reddy visits pharma blast site, announces ₹1 crore ex-gratia for victims’ families

Chief Minister Revanth Reddy visits pharma blast site, announces ₹1 crore ex-gratia for victims’ families

Chief Minister A. Revanth Reddy interacting with the families of the victims of a reactor blast that took place at Sigachi Industries in Sangareddy district on Tuesday (July 01). | Photo Credit: MOHD ARIF Telangana Chief Minister A. Revanth Reddy visited the Sigachi Industries Pvt. Ltd unit in Pashamylaram Industrial area in Sangareddy district on … Read more

Market in a phase of time correction; recovery to be gradual: Sanjay H Parekh

Market in a phase of time correction; recovery to be gradual: Sanjay H Parekh

“It is a very-very good liquidity provision they have done. Now, followed up with another repo rate cut and changing the stance from neutral to accommodative and clearly directionally telling that we are pro-growth now,” says Sanjay H Parekh, Sohum Asset Managers.The verdict is out. If you look at the RBI stance, there is a … Read more

FII selling nearing saturation point; valuations shifting to comfort zone: Rahul Veera

FII selling nearing saturation point; valuations shifting to comfort zone: Rahul Veera

“We believe from here on there would not be major gains, all the profit booking by FII that we have seen in the past six months, the intensity will cool off from here on,” says Rahul Veera, Nippon India AIF.So many moving parts within the globe. Help us analyse where the entire emerging market versus … Read more

Focus on midcaps for alpha generation amidst market uncertainty: Aman Chowhan

Focus on midcaps for alpha generation amidst market uncertainty: Aman Chowhan

“There has been some pickup, whether in GDP numbers, in earnings growth, or in top line or something for it to get some trigger or some reason to be bullish about or to add on to what the current holding is, so that is what the whole situation is,” says Aman Chowhan, Abakkus Asset Manager.Let … Read more

Earnings weakness to persist through Q3, but strong balance sheets set India up for 2025 growth: Sanjay H Parekh

Earnings weakness to persist through Q3, but strong balance sheets set India up for 2025 growth: Sanjay H Parekh

“RBI certainly has a very strong balance sheet and balance of payment situation is also very good. Corporate balance sheet has the lowest leverage. Banking balance sheet is best ever,” says Sanjay H Parekh, Sohum Asset Managers.How are you looking at the markets at this juncture post the sharp selloff that we have seen in … Read more

How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains

How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains

“There should be an alternate vendor that can support you, even if at higher prices or higher cost. So, I think that is where the Indian players come in. Remember, last we checked, Indian API exports were around $4 billion and that number compares to China’s API exports of roughly $40 billion,” says Aditya Khemka, … Read more